Postchemotherapy resections of residual masses from metastatic non-seminomatous testicular germ cell tumors (Q40891967)

24 September 2017

Postchemotherapy resections of residual masses from metastatic non-seminomatous testicular germ cell tumors (English)

1 reference

24 September 2017

J T Hartmann

1

1 reference

24 September 2017

H J Schmoll

2

1 reference

24 September 2017

M A Kuczyk

3

1 reference

24 September 2017

M Candelaria

4

1 reference

24 September 2017

C Bokemeyer

5

1 reference

24 September 2017

language of work or name

1 reference

1 June 1997

1 reference

24 September 2017

1 reference

24 September 2017

8

1 reference

24 September 2017

6

1 reference

24 September 2017

531-538

1 reference

Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors

24 September 2017

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200425854

7 January 2021

Nerve sparing retroperitoneal lymphadenectomy after primary chemotherapy for metastatic testicular carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200425854

7 January 2021

Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200425854

7 January 2021

Outcome analysis for patients with persistent nonteratomatous germ cell tumor in postchemotherapy retroperitoneal lymph node dissections

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200425854

7 January 2021

Results of adjuvant surgery in patients with stage III and IV nonseminomatous testicular tumors after cisplatin-vinblastine-bleomycin chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200425854

7 January 2021

Cisplatin-based combination chemotherapy for disseminated germ cell tumors: long-term follow-up

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200425854

7 January 2021

Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreduction

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200425854

7 January 2021

Prognostic factors for relapse after complete response in patients with metastatic germ cell tumors.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200425854

7 January 2021

Post-chemotherapy surgery in advanced non-seminomatous germ-cell testicular tumours: the significance of histology with particular reference to differentiated (mature) teratoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200425854

7 January 2021

Para-aortic lymphadenectomy after chemotherapy for metastatic non-seminomatous germ cell tumours: prognostic value and therapeutic benefit

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200425854

7 January 2021

Correlation of computerized tomographic changes and histological findings in 80 patients having radical retroperitoneal lymph node dissection after chemotherapy for testis cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200425854

7 January 2021

Prognostic factors for favorable outcome in disseminated germ cell tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200425854

7 January 2021

Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200425854

7 January 2021

Cisplatin, etoposide, ifosfamide, vincristine and bleomycin combination chemotherapy for far advanced testicular carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200425854

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200425854

7 January 2021

Predictors of residual mass histology following chemotherapy for metastatic non-seminomatous testicular cancer: a quantitative overview of 996 resections

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200425854

7 January 2021

The growing teratoma syndrome

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200425854

7 January 2021

Histology and DNA contents of a secondary malignancy arising in a mature residual lesion six years after chemotherapy for a disseminated nonseminomatous testicular tumor

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200425854

7 January 2021

Sarcoma arising in a residual testicular teratoma after cytoreductive chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200425854

7 January 2021

Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200425854

7 January 2021

Sequential resection of residual abdominal and thoracic masses after chemotherapy for metastatic non-seminomatous germ cell tumours

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200425854

7 January 2021

Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200425854

7 January 2021

Sequential excision of residual thoracic and retroperitoneal masses after chemotherapy for stage III germ cell tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200425854

7 January 2021

The Importance of One-Stage Median Sternotomy and Retroperitoneal Node Dissection in Disseminated Testicular Cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200425854

7 January 2021

Post-chemotherapy lymph node histology in radiologically normal patients with metastatic nonseminomatous testicular cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200425854

7 January 2021

The importance of prognostic factors in the individual treatment of patients with disseminated germ cell tumours

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200425854

7 January 2021

Outcome analysis after post-chemotherapy surgery in patients with non-seminomatous germ cell tumours

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200425854

7 January 2021

Prognosis after resection of residual masses following chemotherapy for metastatic nonseminomatous testicular cancer: a multivariate analysis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200425854

7 January 2021

Persistent cancer in postchemotherapy retroperitoneal lymph-node dissection: outcome analysis.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200425854

7 January 2021

Excision of residual masses after platinum based chemotherapy for non-seminomatous germ cell tumours

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200425854

7 January 2021

Salvage treatment in male patients with germ cell tumours

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200425854

7 January 2021

The management of advanced testicular teratoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200425854

7 January 2021

Residual pulmonary masses after chemotherapy for metastatic nonseminomatous germ cell tumor. Prediction of histology. ReHiT Study Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200425854

7 January 2021

Positron emission tomography evaluation of residual radiographic abnormalities in postchemotherapy germ cell tumor patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200425854

7 January 2021

Identifiers

DOI

10.1023/A:1008200425854

1 reference

24 September 2017

1 reference